You are here: Industry Insights > regulatory

News List

Pharmaceutical Supply Chain Management: Challenges and How to Mitigate Them Muhammad Asim Niazi
March 31, 2025
Supply chain management in the pharma industry ensures the product’s efficacy, quality and fulfills patient’s requirements at the right place and right time.
Pharmaceutical Drug Policies: A Comparative Analysis Across Nations Saher Haider
July 02, 2024
Pharmaceutical products are the heart of the healthcare system, yet their accessibility remains a challenge for people across the globe.
New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Can Deliver 30% Savings, Halve Timelines and Cut Risks for Biotechs PharmaSources
June 05, 2024
New research showes that biotechs can save more than 30% in costs, halve start-up times, and cut risk with CROs that have in-house scientific and regulatory affairs.
Continuous Manufacturing Part 3: Batch Size And Control Strategies Deepak Hegde
May 18, 2021
This paper shows the definition of batch in continuous manufacturing, its importance from a regulatory perspective.
MHRA joins international regulatory consortium europeanpharmaceuticalreview
October 22, 2020
By joining the Access Consortium, the MHRA will work together with agencies from Australia, Canada, Singapore and Switzerland to expedite therapeutic product approvals.
Industry positive about CDSCO’s move to digitalise regulatory approvals expresspharma
October 22, 2020
Central Drugs Standard Control Organisation (CDSCO) plans to adopt a paperless office culture and is in the process of going completely digital for regulatory approvals. Recently, Dr S Eswara Reddy, Joint Drugs Controller, CDSCO had informed that ...
FDA transitions to new regulatory pathway for biosimilars europeanpharmaceuticalreview
March 25, 2020
The US FDA will now approve biosimilars via a new regulatory pathway to help grow the competition between biologic products.
Strengthened regulatory systems are needed to improve drug safety, says report europeanpharmaceuticalreview
January 17, 2020
The report reveals practical regulatory reforms that could move the globe closer to the UN’s goal of achieving universal health coverage by 2030.
OssDsign AB (publ) Initiates Commercial Preparations for Launch in Japan Following Regulatory Filing for OssDsign Cranial prnasia
August 12, 2019
OssDsign AB (publ) ("OssDsign" or the "Company"), the Swedish designer and manufacturer of innovative implants for bone regeneration, has filed for a Japanese regulatory approval of OssDsign Cranial.
Sun Pharma announces regulatory filing of Tildrakizumab in Japan biospectrumasia
August 01, 2019
Filing is a significant milestone in establishing the specialty business in Japan and adds one more potential market for Tildrakizumab globally